CORDIS - Forschungsergebnisse der EU
CORDIS

“DNA-based NANOdevices for the point-of-care electrochemical detection of AntiBodies”

Projektbeschreibung

DNS-basierte Antikörpererkennungsplattformen zur vereinfachten Diagnose

Die Antikörpererkennung ist für die Diagnose vieler gesundheitlicher Beeinträchtigungen unerlässlich, darunter Infektions-, Autoimmun- und onkologische Erkrankungen. Das EU-finanzierte Projekt DNA-NANO-AB zielt auf die Entwicklung DNS-basierter, schneller, anwendungsfreundlicher, empfindlicher und kostengünstiger elektrochemischer Nanogeräte für die Erkennung klinisch relevanter Antikörper ab, die als patientennahe Anwendung eingeführt werden könnten. Somit konzentriert sich die Arbeit des Projekts auf die rationale Konzipierung und Herstellung von DNS-basierten Einweg-Sensorplattformen, welche die Erkennung spezifischer Antikörper über einen elektrochemischen Ausgabeansatz verbessern. Die entwickelten Plattformen werden unter Verwendung des Immunoglobulinniveaus in realen repräsentativen Proben charakterisiert, optimiert und getestet.

Ziel

WHY: Antibody detection plays a pivotal role in the diagnosis of many human disorders including infectious, autoimmune, and oncological diseases. Unfortunately, current methods routinely used for the detection of these biomarkers still require sophisticated equipment, washing intensive, reagent-intensive multi-step processes. In attempt to overcome the cited limitations, it’s mandatory find new approaches for the sensitive detection of antibodies.
WHAT: DNA-NANO-AB proposes the development of DNA-based novel, rapid, user friendly, robust, sensitive and low cost electrochemical NANOdevices for orthogonal multiplex detection of antibodies that may be advantageous over existing methods for the detection of clinically-relevant antibodies and could be well-positioned for point-of-care applications.
I will achieve this goal by rationally designing and fabricating disposable DNA-based sensing platforms in which the detection of specific antibodies will be signaled, and amplified, through an electrochemical read-out approach. The developed platforms will be characterized, optimized and then tested for the dosage of immunoglobulins levels directly in real representative samples.
HOW: During the fellowship I will undertake a training program to develop skills and acquire expertise in molecular biology, electrochemical biosensor and DNA Nanotechnology. To achieve these objectives, I will combine the different scientific backgrounds and expertise of two leading scientists: Prof. Plaxco (University of California Santa Barbara), a world-wide expert in electrochemical biosensors, and Prof. Ricci (University of Rome, Tor Vergata), a young researcher active at the forefront of DNA nanotechnology for diagnostic and drug-delivery applications. Thanks to this MSC Fellowship, I will diversify my scientific knowledge and acquire cutting-edge competences as well as complementary skills, which will become the foundation of my scientific independence.

Koordinator

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Netto-EU-Beitrag
€ 251 002,56
Adresse
VIA CRACOVIA 50
00133 Roma
Italien

Auf der Karte ansehen

Region
Centro (IT) Lazio Roma
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 251 002,56

Partner (1)